ArticleJTCVS open2026
Does pre-operative left ventricular function predict mitral valve function after anomalous left coronary artery from the pulmonary artery repair?
Article in JTCVS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To compare the progression of mitral valve (MV) function before and after anomalous left coronary artery from the pulmonary artery (ALCAPA) repair in those with preserved versus impaired left ventricular (LV) function. Methods: This is a post-hoc analysis of patients who underwent repair for ALCAPA at 22 Collaborative Research from the Pediatric Cardiac Intensive Care Society centers. Mitral regurgitation (MR) severity was compared on the basis of LV function at diagnosis and through 3 years of follow-up. Results: Among 228 patients, 76 had normal/mild LV dysfunction and 152 had moderate/severe LV dysfunction (median ejection fraction 60% vs 23%, Conclusions: In patients with ALCAPA and MV dysfunction with preserved LV function, MV recovery is less common, highlighting the consideration for concomitant MV repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.